Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats
Open Access
- 1 December 1985
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 52 (6) , 937-939
- https://doi.org/10.1038/bjc.1985.280
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- High-Dose Cisplatin in Hypertonic SalineAnnals of Internal Medicine, 1984
- PLASMA PLATINUM LEVELS - RELATIONSHIP TO CISPLATIN DOSE AND NEPHROTOXICITY1983
- Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)European Journal of Cancer and Clinical Oncology, 1982
- ACUTE AND CHRONIC CISPLATIN NEPHROPATHY IN RATS1981
- The Development of Mesna for the Inhibition of Urotoxic Side Effects of Cyclophosphamide, Ifosfamide, and Other Oxazaphosphorine CytostaticsPublished by Springer Nature ,1980
- CONTROLLED CLINICAL STUDIES WITH AN ANTIDOTE AGAINST THE UROTOXICITY OF OXAZAPHOSPHORINES - PRELIMINARY-RESULTS1979
- Cis-diamminedichloroplatinum (II)Annals of Internal Medicine, 1977
- High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresisCancer, 1977
- Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.1971
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969